Cullin 3 Promotes Proteasomal Degradation of the Topoisomerase I-DNA Covalent Complex

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-2858PMID 14871846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcription-Dependent Degradation of Topoisomerase I-DNA Covalent Complexes

  2003cited by this paper
• Clinical update: proteasome inhibitors in hematologic malignancies.

  2003cited by this paper
• Clinical update: proteasome inhibitors in solid tumors.

  2003cited by this paper
• Proteasome inhibition: a new pathway in cancer therapy

  2003cited by this paper
• SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin

  2002cited by this paper
• Development of the proteasome inhibitor PS-341.

  2002cited by this paper
• Kinetic studies of human tyrosyl-DNA phosphodiesterase, an enzyme in the topoisomerase I DNA repair pathway.

  2002cited by this paper
• CUL7: A DOC domain-containing cullin selectively binds Skp1⋅Fbx29 to form an SCF-like complex

  2002cited by this paper
• Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.

  2002cited by this paper
• Distinct protein degradation mechanisms mediated by Cul1 and Cul3 controlling Ci stability in Drosophila eye development.

  2002cited by this paper
• Mechanisms underlying ubiquitination.

  2001cited by this paper
• Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.

  2001cited by this paper
• Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.

  2001cited by this paper
• SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage.

  2000cited by this paper
• NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.

  2000cited by this paper
• Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.

  2000cited by this paper
• Vascular Factors in Cognitive Impairment‐Where Are We Now?

  2000cited by this paper
• Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells.

  1999cited by this paper
• Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.

  1999cited by this paper
• Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein.

  1999cited by this paper
• Glucose‐regulated stresses cause degradation of DNA topoisomerase IIα by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells

  1999cited by this paper
• ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity.

  1999cited by this paper
• Degradation of topoisomerase I induced by topoisomerase I inhibitors is dependent on inhibitor structure but independent of cell death.

  1999cited by this paper
• Identification of a cullin homology region in a subunit of the anaphase-promoting complex.

  1998cited by this paper
• Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast.

  1998cited by this paper
• Cloning and Expression Analysis of a Novel Salicylate Suppressible Gene, Hs-CUL-3, a Member of Cullin/Cdc53 Family*

  1998cited by this paper
• Ubiquitin-dependent Destruction of Topoisomerase I Is Stimulated by the Antitumor Drug Camptothecin*

  1997influential reference
• Processing of topoisomerase I cleavable complexes into DNA damage by transcription.

  1997cited by this paper
• The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.

  1997influential reference
• Mechanism of Action of Camptothecin

  1996cited by this paper
• Camptothecin Resistance Related to Drug‐induced Down‐Regulation of Topoisomerase I and to Steps Occurring after the Formation of Protein‐linked DNA Breaks a

  1996cited by this paper
• Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen.

  1995cited by this paper
• The mechanisms of DNA topoisomerases.

  1995cited by this paper
• Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.

  1995cited by this paper
• DNA topoisomerases: essential enzymes and lethal targets.

  1994cited by this paper
• Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.

  1991cited by this paper
• Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody.

  1990cited by this paper
• Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.

  1990cited by this paper
• Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.

  1989cited by this paper
• Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.

  1988cited by this paper
• DNA topoisomerases and DNA repair

  1988cited by this paper
• Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

  1986cited by this paper
• Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

  1985cited by this paper
• Components of Ubiquitin-Protein Ligase System

  1983cited by this paper
• Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown.

  1983cited by this paper

• Post-Translational Modifications Orchestrate Repair of Trapped Topoisomerase-Induced DNA Breaks via TDP1 and TDP2.

  2025cites this paper
• From the TOP: Formation, recognition and resolution of topoisomerase DNA protein crosslinks.

  2024cites this paper
• Autophagy as a way to remove DNA lesions

  2024cites this paper
• TEX264-mediated selective autophagy directs DNA damage repair.

  2024cites this paper
• TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survival.

  2024cites this paper
• C-terminal residues of DNA polymerase β and E3 ligase required for ubiquitin-linked proteolysis of oxidative DNA-protein crosslinks.

  2024cites this paper
• Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin

  2023cites this paper
• A Tale of Two-Hybrids: Investigating the Interactomes of Cullin-Associated Proteins

  2022cites this paper
• NEDDylated Cullin 3 mediates the adaptive response to topoisomerase 1 inhibitors

  2022influential citation
• Human topoisomerases and their roles in genome stability and organization

  2022cites this paper
• Targeting DNA-Protein Crosslinks via Post-Translational Modifications

  2022cites this paper
• Transcription-associated DNA breaks and cancer: A matter of DNA topology.

  2021cites this paper
• SUMO orchestrates multiple alternative DNA-protein crosslink repair pathways

  2020cites this paper
• KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease

  2020cites this paper
• Debulking of topoisomerase DNA-protein crosslinks (TOP-DPC) by the proteasome, non-proteasomal and non-proteolytic pathways.

  2020cites this paper
• Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases

  2020cites this paper
• The DNA Replication Machinery as Therapeutic Targets

  2019cites this paper
• Repair pathway for PARP-1 DNA-protein crosslinks.

  2019cites this paper
• Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy

  2018cites this paper
• DNA protein crosslink proteolysis repair: From yeast to premature ageing and cancer in humans

  2018cites this paper
• Investigating the role of Tyrosyl-DNA Phosphodiesterase 1 in nuclear and mitochondrial DNA repair

  2017cites this paper
• Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies

  2017cites this paper
• CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing

  2016cites this paper
• Delivery of Targeted Nanoparticles Across the Blood-Brain Barrier Using a Detachable Targeting Ligand

  2016cites this paper
• DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions

  2015cites this paper
• DNA double-strand break formation and signalling in response to transcription-blocking topoisomerase I complexes

  2015influential citation
• The distinctive cellular responses to DNA strand breaks caused by a DNA topoisomerase I poison in conjunction with DNA replication and RNA transcription.

  2015cites this paper
• The Significance of CRISPR/Cas9-Directed CUL3 Knockout on Human Colorectal Cancer Cells

  2015cites this paper
• Tipin Functions in the Protection against Topoisomerase I Inhibitor*

  2014cites this paper
• Drugging topoisomerases: lessons and challenges.

  2013cites this paper
• Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p.

  2013cites this paper
• Topoisomerase IIβ Deficiency Enhances Camptothecin-induced Apoptosis*

  2013cites this paper
• Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.

  2013cites this paper
• Length , Splice Sites , and miR-1423 p Transcription Poisoning by Topoisomerase I Is Controlled by Gene

  2013cites this paper
• Discovery and application of colorectal cancer protein markers for disease stratification

  2013cites this paper
• Ubiquitin and Ubiquitin-Like Proteins in Repair of Topoisomerase-Mediated DNA Damage

  2012cites this paper
• Rescue of the genetically engineered Cul4b mutant mouse as a potential model for human X-linked mental retardation.

  2012cites this paper
• Spinocerebellar Ataxia with Axonal Neuropathy (SCAN1): A Disorder of Nuclear and Mitochondrial DNA Repair

  2012cites this paper
• Isolation and Quantitation of Topoisomerase Complexes Accumulated on Escherichia coli Chromosomal DNA

  2012cites this paper
• SCF E3 Ubiquitin Ligases as Anticancer Targets

  2012cites this paper
• Calcium-induced cleavage of DNA topoisomerase I involves the cytoplasmic-nuclear shuttling of calpain 2

  2011cites this paper
• CUL4B-deficiency in humans: understanding the clinical consequences of impaired Cullin 4-RING E3 ubiquitin ligase function.

  2011cites this paper
• A Blm-Recql5 partnership in replication stress response.

  2011cites this paper
• SCF Complex E3 Ubiquitin Ligases as Anticancer Targets

  2011cites this paper
• SCF E3 ubiquitin ligases as anticancer targets.

  2011cites this paper
• A tyrosyl DNA phosphodiesterase 1 from kinetoplastid parasite Leishmania donovani (LdTdp1) capable of removing topo I–DNA covalent complexes

  2010cites this paper
• Robust Semiparametric Regression Estimation Using Targeted Maximum Likelihood with Application to Biomarker Discovery and Epidemiology

  2010cites this paper
• An ex vivo familial genetics strategy for determining mechanism of action

  2010cites this paper
• Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks.

  2010cites this paper
• Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks*

  2009cites this paper
• The Cul3/Klhdc5 E3 Ligase Regulates p60/Katanin and Is Required for Normal Mitosis in Mammalian Cells*

  2009cites this paper
• Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.

  2009cites this paper
• RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival

  2009cites this paper
• The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2α Cleavage Complex – A Potentially New Drug Target

  2009cites this paper
• An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases

  2009cites this paper
• RBX 1 / ROC 1-SCF E 3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival

  2009cites this paper
• A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes*

  2008cites this paper
• Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors

  2008cites this paper
• Targeted Methods for Biomarker Discovery, the Search for a Standard

  2008cites this paper
• A novel ATP-binding cassette transporter, ABCG6 is involved in chemoresistance of Leishmania.

  2008cites this paper
• Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors.

  2008cites this paper
• Inference of Protein Complex Activities from Chemical-Genetic Profile and Its Applications: Predicting Drug-Target Pathways

  2008cites this paper
• ISG15 as a novel tumor biomarker for drug sensitivity

  2008cites this paper
• Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.

  2008cites this paper
• Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases.

  2008cites this paper
• Functional interactions of DNA topoisomerases with a human replication origin

  2007cites this paper
• TDP1 facilitates repair of ionizing radiation-induced DNA single-strand breaks.

  2007cites this paper
• Constitutive Turnover of Cyclin E by Cul3 Maintains Quiescence

  2007cites this paper
• Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1

  2006cites this paper
• Synthesis and biological evaluation of 10,11-methylenedioxy-14-azacamptothecin.

  2006cites this paper
• New molecular mechanisms of action of camptothecin-type drugs.

  2006cites this paper
• The Novel Poly(ADP-Ribose) Polymerase Inhibitor, AG14361, Sensitizes Cells to Topoisomerase I Poisons by Increasing the Persistence of DNA Strand Breaks

  2005cites this paper
• A structure-based method for identifying DNA-binding proteins and their sites of DNA-interaction

  2005cites this paper
• Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase.

  2005cites this paper
• Sensitization of DNA damage–induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3σ and survivin

  2005cites this paper